APAC IPOs & Placements, Aequitas Research

Nicholas Tan

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/coree-company-limited" target="_blank" data-smartkarma-citation="entities:46173:1" rel="noopener">COREE (COREE HK)</a> is looking to raise at least US$100m in its upcoming Hong Kong IPO. The deal will be run by CICC.</li>
<li>COREE is a leading integrated healthcare solution provider in China.</li>
<li>It focuses on the specialized pediatric medicine marketing, promotion, and sales market as well as the bio-health sector.</li>
</ul>



COREE (COREE HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO. The deal will be run by CICC.
COREE is a leading integrated healthcare solution provider in China.
It focuses on the specialized pediatric medicine marketing, promotion, and sales market as well as the bio-health sector.


COREE

COREE Co Pre-IPO Tearsheet